Lonidamine is a derivative of indazole-3-carboxylic acid which for a long time has been known to inhibit aerobic glycolysis in cancer cells. It seems to enhance aerobic glycolysis in normal cells but suppress glycolysis in cancer cells. This is most likely through the inhibition of the mitochondrially bound hexokinase.
This page contains content from the copyrighted Wikipedia article "Lonidamine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
